We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Medherant Appoints Sheryl Caswell to Lead Clinical Development of Products

News   Jun 07, 2017 | Original Story from Medherant

 
Medherant Appoints Sheryl Caswell to Lead Clinical Development of Products
 
 
 

RELATED ARTICLES

Enabling Technology in Cell-Based Therapies: Scale-Up, Scale-Out or Program In-Place

News

Technologies are reducing costs and changing the ways in which researchers and clinicians process and use therapeutic cells. Two new review articles detail the status of cell bioreactors in both stem cell and tissue/organ engineering applications.

READ MORE

T Cells Attack and Kill Dopamine-Producing Cells in Parkinson's disease

News

Researchers in Germany discover a potential new target for treating Parkinson's disease

READ MORE

Kidney Cancer Driver Could Lead to New Treatment Strategy

News

Scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change can lead to an overabundance of blood vessels, which help feed nutrients to the tumors. Their latest finding shows a potential new cancer-driving pathway.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE